Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4093-4099

  Amani, Véronique ^a   Boubou, Mariama Idrissa ^a   Pied, Sylviane ^a   Marussig, Myriam ^a   Walliker, David ^b   Mazier, Dominique ^a   Rénia, Laurent ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CLONING; CONTROLLED STUDY; HYPOTHERMIA; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0031690171     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.66.9.4093-4099.1998     Document Type: Article

References (45)

1. Alger, N. A., M. Branton, J. Harant, and P. H. Silverman. 1971. Plasmodium berghei NK65 in the inbred A/J mouse. Variations in virulence of P. berghei demes. J. Protozool. 18:598-601.
2. Alger, N. A., M. Branton, and P. H. Silverman. 1977. Plasmodium berghei NK65 in the inbred A/J mouse: immunity in the A/J mouse naturally recovered from NK65C and challenged with NK65E. J. Protozool. 19:516-518.
3. Baruch, D. J., B. L. Pasloke, H. B. Singh, X. Bi, X. C. Ma, M. Feldman, T. F. Tarashi, and R. J. Howard. 1995. Cloning the P. falciparum gene encoding PfEMP1, a malaria variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82:77-88.
4. Berendt, A. R., G. D. H. Turner, and C. I. Newbold. 1994. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 10:412-414.
5. Clark, I. A., K. A. Rockett, and W. B. Cowden. 1992. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340: 894-896.
6. Clark, I. A., and K. A. Rockett. 1994. The cytokine theory of human cerebral malaria. Parasitol. Today 10:410-412.
7. Contreras, C. E., C. H. June, L. H. Perrin, and P.-H. Lambert. 1980. Immunopathological aspects of Plasmodium berghei infection in five strains of mice. I. Immune complexes and other serological features during the infection. Clin. Exp. Immunol. 42:403-411.
8. Curfs, J. H. A. J., T. P. M. Schetters, C. C. Hermsen, C. R. Jerusalem, A. Van Zon, and W. M. C. Eling. 1988. Immunological aspects of cerebral lesions in murine malaria. Clin. Exp. Immunol. 74:136-140.
9. Curfs, J. H. A. J., C. C. Hermsen, J. H. E. T. Meuwissen, and W. M. C. Eling. 1992. Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology 105:7-14.
10. Curfs, J. H. A. J., P. H. Van Der Meide, A. Billiau, J. H. E. T. Meuwissen, and W. M. C. Eling. 1993. Plasmodium berghei: recombinant interferon-γ and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp. Parasitol. 77:212-223.
11. + cell-mediated pathology. Proc. Natl. Acad. Sci. USA 91:8097-8101.
12. Eling, W., A. Van Zon, and C. Jerusalem. 1977. The course of a Plasmodium berghei infection in six different mouse strains. Z. Parasitenkd. 54:29-45.
13. Eling, W. M. C., and P. G. Kremsner. 1994. Cytokines in malaria, pathology and infection. Biotherapy 7:211-221.
14. Falanga, P. B., and E. C. Butcher. 1991. Late treatment with anti-LFA1 (CD11a) antibody prevents cerebral malaria in a mouse model. Eur. J. Immunol. 21:2259-2260.
15. Finley, R. W., J. Mackey, and P.-H. Lambert. 1982. Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in T cell deficient nude mice. J. Immunol. 129:2213-2217.
16. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P.-H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212.
17. Grau, G. E., V. Kindler, P. F. Piguet, P.-H. Lambert, and P. Vassalli. 1988. Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation. J. Exp. Med. 168:1499-1504.
18. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P.-H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon-gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86:5572-5574.
19. Grau, G. E., T. E. Taylor, M. E. Molyneux, J. J. Wirima, P. Vassalli, M. Hommel, and P.-H. Lambert. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-1589.
20. Grau, G. E., P. F. Piguet, P. Vassalli, and P.-H. Lambert. 1989. Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:49-70.
21. Grau, G. E., G. Bieler, S. De Kossodo, F. Tacchini-Cottier, P. Vassalli, P. F. Piguet, and P.-H. Lambert. 1990. Significance of cytokine production and adhesion molecules in malarial immunopathology. Immunol. Lett. 25:189-194.
22. Grau, G. E., P. Pointaire, P. F. Piguet, C. Vesin, H. Rosen, I. Stamenkovic, F. Takei, and P. Vassalli. 1991. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 21:2265-2267.
23. Grau, G. E., and S. de Kossodo. 1994. Cerebral malaria: mediators, mechanical obstruction or more. Parasitol. Today 10:408-410.
24. Greenberg, J. 1955. Differences in the course of Plasmodium berghei infections in some hybrid and backcross mice. Am. J. Trop. Med. Hyg. 5:19-28.
25. Greenberg, J., and L. P. Kendrick. 1956. Parasitaemia and survival in inbred strains of mice infected with Plasmodium berghei. J. Parasitol. 43:413-420.
26. Greenberg, J., and L. P. Kendrick. 1957. Some characteristics of Plasmodium berghei passed within inbred strains of mice. J. Parasitol. 43:420-428.
27. Hermsen, C. C., J. V. D. Crommert, R. W. Sauerwein, and W. C. M. Eling. 1997. Circulating tumor necrosis factor α is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57BL mice. Parasite Immunol. 19:571-577.
28. Hill, A. V. S., C. E. M. Allsopp, D. Kwiatkowski, M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, A. J. McMichael, A. R. Townsend, and B. M. Greenwood. 1991. Common West African HLA Ag are associated with protection from severe malaria. Nature 352:595-600.
29. Jennings, V. M., J. K. Actor, A. A. Lal, and R. L. Hunter. 1997. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 65:4883-4887.
30. Kern, P., C. J. Hemmer, H.-J. Grass, and M. Dietrich. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:139-143.
31. Kwiatkowski, D., A. V. S. Hill, L. Sambou, P. Twumasi, J. Castracane, K. Manogue, A. Cerami, D. Brewster, and B. M. Greenwood. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204.
32. Mackey, L. J., A. Hochmann, C. H. June, C. E. Contreras, and P.-H. Lambert. 1980. Immunological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and tissue lesions during the infection. Clin. Exp. Immunol. 42:412-420.
33. Maegraith, B. 1974. Other pathological processes in malaria. Bull. W. H. O. 50:187-193.
34. Neill, A. L., and N. H. Hunt. 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105:165-175.
35. Patnaik, J. K., B. S. Das, S. K. Mishra, S. Mohanty, S. K. Satpathy, and D. Mohanty. 1994. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am. J. Trop. Med. Hyg. 51:642-647.
36. Polder, T. H., W. M. C. Eling, J. H. A. J. Curfs, C. R. Jerusalem, and M. Wijers-Rouw. 1992. Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden. 60:31-46.
37. Porta, J., A. Carola, G. P. Pizzolato, E. Wildi, M. C. Wildmer, C. Marguiraz, and G. E. Grau. 1993. Immunopathological changes in human cerebral malaria. Clin. Neuropathol. 12:142-146.
38. Rest, J. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76:410-415.
39. Roberts, D. J., A. G. Craig, A. R. Berendt, R. Pinches, G. Nash, K. Marsh, and C. I. Newbold. 1992. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689-692.
40. Rudin, W., H.-P. Eugster, G. Bordmann, J. Bonato, M. Müller, M. Yamage, and B. Ryffel. 1997. Resistance to cerebral malaria in tumor necrosis factor-α/β-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 150: 257-266.
41. Russel, A. S., and C. H. June. 1980. On the nature of early mortality in murine malaria. J. Parasitol. 66:1065-1066.
42. Smith, J. D., C. E. Chitnis, A. G. Craig, D. J. Roberts, D. E. Hudson-Taylor, D. S. Peterson, R. Pinches, C. I. Newbold, and L. H. Miller. 1995. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82:101-113.
43. Su, X. S., V. M. Heatwole, S. P. Wertheimer, F. Guinet, J. A. Herrfeldt, D. S. Peterson, J. A. Ravetch, and T. E. Wellems. 1995. The large diverse gene family var encodes proteins in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82:89-100.
44. Wery, M., J. Weyn, G. Timperman, and L. Hendrix. 1979. Observations on the virulence and the antigenic characters of cloned and uncloned lines of the ANKA isolate of Plasmodium berghei. 1. Production of recrudescent parasitaemias in immunized mice. Ann. Soc. Belge Med. Trop. 59:347-360.
45. White, N., and M. Ho. 1992. The pathophysiology of malaria. Adv. Parasitol. 31:84-173.